南新制药股价下跌5.05% 抗流感业务承压与资金博弈共振

智选洞察2025-07-16

南新制药股价大幅下跌，最新价9.58元/股，跌幅达5.05%。资金博弈与政策预期共振南新制药近期股价波动呈现典型资金博弈特征。截至7月14日，主力资金单日净流入3339.8万元，较前一日净流出268.6万元实现逆转，机构专用席位当日买入2177.9万元，游资与机构分歧明显。政策扰动加剧波动，7月9日创新药支付端调整引发资金撤离，次日公司196.7万元回购计划带动部分资金回流。板块层面，化学制药行业...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2551314116?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-07-16 09:37","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2551314116","market":"sh","top_or_hot":-1,"title":"南新制药股价下跌5.05% 抗流感业务承压与资金博弈共振","media":"智选洞察","content":"<div>\n<p>南新制药股价大幅下跌，最新价9.58元/股，跌幅达5.05%。资金博弈与政策预期共振南新制药近期股价波动呈现典型资金博弈特征。截至7月14日，主力资金单日净流入3339.8万元，较前一日净流出268.6万元实现逆转，机构专用席位当日买入2177.9万元，游资与机构分歧明显。政策扰动加剧波动，7月9日创新药支付端调整引发资金撤离，次日公司196.7万元回购计划带动部分资金回流。板块层面，化学制药行业...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716093842a6ac38af&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>南新制药股价下跌5.05% 抗流感业务承压与资金博弈共振</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n南新制药股价下跌5.05% 抗流感业务承压与资金博弈共振\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-07-16 09:37 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716093842a6ac38af&s=b><strong>智选洞察</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>南新制药股价大幅下跌，最新价9.58元/股，跌幅达5.05%。资金博弈与政策预期共振南新制药近期股价波动呈现典型资金博弈特征。截至7月14日，主力资金单日净流入3339.8万元，较前一日净流出268.6万元实现逆转，机构专用席位当日买入2177.9万元，游资与机构分歧明显。政策扰动加剧波动，7月9日创新药支付端调整引发资金撤离，次日公司196.7万元回购计划带动部分资金回流。板块层面，化学制药行业...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716093842a6ac38af&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"688189","symbol_name":"ST南新","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716093842a6ac38af&s=b","article_id":"2551314116","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716093842a6ac38af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2551314116","pubTimestamp":1752629879,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"南新制药股价大幅下跌，最新价9.58元/股，跌幅达5.05%。资金博弈与政策预期共振南新制药近期股价波动呈现典型资金博弈特征。政策扰动加剧波动，7月9日创新药支付端调整引发资金撤离，次日公司196.7万元回购计划带动部分资金回流。抗流感赛道价值重塑路径作为抗流感药物细分龙头，南新制药该领域营收占比75.08%，但2025年一季度营收同比下滑70.21%，业绩修复仍需观察。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"688189":"ST南新","BK0239":"医药制造"},"translate_title":"Nanxin Pharmaceutical's stock price fell 5.05%, the anti-influenza business was under pressure and the capital game resonated","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"688189":1},"content_text":"南新制药股价大幅下跌，最新价9.58元/股，跌幅达5.05%。资金博弈与政策预期共振南新制药近期股价波动呈现典型资金博弈特征。截至7月14日，主力资金单日净流入3339.8万元，较前一日净流出268.6万元实现逆转，机构专用席位当日买入2177.9万元，游资与机构分歧明显。政策扰动加剧波动，7月9日创新药支付端调整引发资金撤离，次日公司196.7万元回购计划带动部分资金回流。板块层面，化学制药行业7月8日单日净流出17.92亿元，资金调仓进一步放大个股波动。抗流感赛道价值重塑路径作为抗流感药物细分龙头，南新制药该领域营收占比75.08%，但2025年一季度营收同比下滑70.21%，业绩修复仍需观察。华福证券研报指出，公司当前1.2倍市销率较行业均值存在30%折价，若三季度流感季销售放量或实现原料药技术突破，估值压制或缓解。技术面显示，8元附近年线形成阻力，股东户数连续两季降至8843户，筹码集中度升至近三年高位。不过，创新药管线仅有1款II期临床产品，产品迭代速度落后同业，或制约长期成长空间。（注：文中数据截至2025年7月14日，主力资金及行情数据经内部金融数据库核验。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2551314116","isCrawlerRequest":true}